---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-090153"
form_type: "8-K"
ticker: "ARMP"
cik: "0000921114"
company_name: "Armata Pharmaceuticals, Inc."
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T09:11:55.516420+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Armata appoints David House as SVP, Finance and principal financial officer

## Summary
- David House appointed SVP, Finance and principal financial officer, effective Aug. 16, 2024.
- Base salary $350,000; target bonus 40% of base; option for 75,000 shares vesting over 4 years.
- Previously Corporate Controller and VP of Accounting at ZO Skin Health (acquired by Blackstone).
- Prior principal financial officer Richard Rychlik will remain as Corporate Controller.

## SEC filing metadata
- accession: 0001104659-24-090153
- form_type: 8-K
- ticker: ARMP
- cik: 0000921114
- company_name: Armata Pharmaceuticals, Inc.
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921114/000110465924090153/0001104659-24-090153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921114/000110465924090153/tm2421653d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-090153
- JSON: https://secwatch.observer/filing/0001104659-24-090153.json
- Plain text: https://secwatch.observer/filing/0001104659-24-090153.txt

## Key facts
- Executive change
  David House was appointed as Senior Vice President, Finance at Armata Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Senior Vice President, Finance
  source text: On July 31, 2024, Armata Pharmaceuticals, Inc. (the “ Company ”) entered into an employment letter agreement (the “ Agreement ”) with David House, pursuant to which he has agreed to serve as the Company’s Senior Vice President, Finance, effective August 16, 2024 (the “ Effective Date ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/921114/000110465924090153/0001104659-24-090153-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.